Safety evaluation of human umbilical cord-mesenchymal stem cells in type 2 diabetes mellitus treatment: A phase 2 clinical trial.

Xiao-Fen Lian,Dong-Hui Lu,Hong-Li Liu,Yan-Jing Liu,Yang Yang, Yuan Lin, Feng Xie,Cai-Hao Huang,Hong-Mei Wu,Ai-Mei Long, Chen-Jun Hui,Yu Shi,Yun Chen, Yun-Feng Gao,Fan Zhang

World journal of clinical cases（2023）

引用 0|浏览7

暂无评分

摘要

Our study suggested that hUC-MSC transplantation has good tolerance and high safety in the treatment of T2DM. It can improve human immunity and inhibit lymphocytes. Coagulation function should be monitored vigilantly for abnormalities.

查看译文

关键词

Type 2 diabetes mellitus, Cell transplantation, Human umbilical cord-mesenchymal stem cells, Safety, Lymphocytes, Immunity

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要